|
|
Line 269: |
Line 269: |
| *[https://sci-hub.wf/10.1093/ntr/ntaa150 PDF] | | *[https://sci-hub.wf/10.1093/ntr/ntaa150 PDF] |
| *Citation: Rachel N Cassidy, Jennifer W Tidey, Suzanne M Colby, Exclusive E-Cigarette Users Report Lower Levels of Respiratory Symptoms Relative to Dual E-Cigarette and Cigarette Users, Nicotine & Tobacco Research, Volume 22, Issue Supplement_1, December 2020, Pages S54–S60, https://doi.org/10.1093/ntr/ntaa150 | | *Citation: Rachel N Cassidy, Jennifer W Tidey, Suzanne M Colby, Exclusive E-Cigarette Users Report Lower Levels of Respiratory Symptoms Relative to Dual E-Cigarette and Cigarette Users, Nicotine & Tobacco Research, Volume 22, Issue Supplement_1, December 2020, Pages S54–S60, https://doi.org/10.1093/ntr/ntaa150 |
|
| |
| ===2020: SACCHARIN TRANSIT TIME IN EXCLUSIVE E-CIGARETTES AND HEATED TOBACCO PRODUCTS USERS: A CROSS-SECTIONAL STUDY===
| |
| Ex-smokers who have switched to exclusive regular use of combustion-free nicotine delivery systems (i.e. ECs/e-cigarettes and HTPs/heated tobacco products) exhibit similar saccharin transit time as never and former smokers. This suggests that combustion-free nicotine delivery technologies are unlikely to have detrimental effects on MCC (mucociliary clearance) function
| |
|
| |
|
| ===2020: [https://journals.sagepub.com/doi/full/10.1177/2040622320961617 COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]=== | | ===2020: [https://journals.sagepub.com/doi/full/10.1177/2040622320961617 COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]=== |